Valeant sells three skincare brands to L'Oreal for $1.3 billion

The company has also sold off Dendreon Pharma to China's Sanpower Group for $ 819.9 mn

Premium

<a href="http://www.shutterstock.com/pic-163535129/stock-photo--colored-plastic-bottles-with-liquid-soap-and-shower-gel-isolated-on-white-background-studio.html?src=7Bo1D9B45NOvlRg1O1irMw-1-14" target="_blank">cosmetics</a> image via Shutterstock.

BS B2B Bureau Quebec, Canada

Last Updated : Jan 10 2017 | 3:22 PM IST

Canada-based Valeant Pharmaceuticals International Inc has entered into an agreement to sell its CeraVe, AcneFree and AMBI skincare brands to L’Oreal for $1.3 billion in cash. In another development, Valeant has sold its stake in Dendreon Pharmaceuticals to China’s Sanpower Group Co Ltd for $819.9 million. The company will use proceeds from both these divestments to permanently repay term loan debt under its senior secured credit facility.

Valeant’s CeraVe, AcneFree, and AMBI product lines have annualised revenue of approximately of $ 168 million. The CeraVe brand portfolio offers a range of advanced skincare products, including cleansers, moisturisers, sunscreens, healing ointments and

What you get on BS Premium?

Unlock 30+ premium stories daily hand-picked by our editors, across devices on browser and app.
Pick your 5 favourite companies, get a daily email with all news updates on them.
Full access to our intuitive epaper - clip, save, share articles from any device; newspaper archives from 2006.
Preferential invites to Business Standard events.
Curated newsletters on markets, personal finance, policy & politics, start-ups, technology, and more.

VIEW ALL FAQs

Need More Information - write to us at assist@bsmail.in